Study guide

11.2 Medication Handling, Delivery, and Calculations on the Sterile Field

Tech in Surgery, Certified NCCT TS-C

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction, Exam Logistics, and Aseptic Principles

1.1 About the NCCT TS-C Exam 1.2 Surgical Microbiology and Infection Transmission 1.3 Principles of Surgical Asepsis and Sterile Field Boundaries 1.4 OR Physical Environment and Engineering Controls

2 Chapter 2: Decontamination, Packaging, and Sterilization Methods

2.1 Spaulding Classification, Point-of-Use Care, and Decontamination 2.2 Steam Sterilization Parameters, Cycles, and Immediate-Use Protocols 2.3 Low-Temperature Sterilization Technologies 2.4 Sterilization Monitoring, Chemical Indicators, and Sterile Storage

3 Chapter 3: Preoperative Case Setup, Infection Precautions, and Perioperative Reporting

3.1 Preoperative Case Setup: Preference Cards, Case Carts, and Sterile Field Arrangement 3.2 Standard and Transmission-Based Precautions, Hand Hygiene, and Hazard Communication 3.3 Perioperative Communication, Surgical Time Out, and Incident Reporting

4 Chapter 4: Perioperative Patient Preparation, Positioning, and Draping

4.1 Patient Identification, Chart Verification, and Safe Transport 4.2 Surgical Patient Positioning and Peripheral Nerve Injury Prevention 4.3 Surgical Skin Antisepsis and Preparation Protocols 4.4 Surgical Hand Scrub, Gowning, and Gloving 4.5 Surgical Draping Principles and Sequence

5 Chapter 5: Surgical Instrumentation, Equipment, and Counts

5.1 Clamping and Occluding Instruments 5.2 Cutting, Dissecting, Grasping, and Holding Instruments 5.3 Retracting and Exposing Instruments 5.4 Suction Devices, Powered Equipment, and Endoscopes 5.5 Surgical Counts and Prevention of Retained Surgical Items

6 Chapter 6: Hemostasis, Energy Modalities, and Surgical Fire Safety

6.1 Hemostasis Modalities and Topical Hemostatic Agents 6.2 Electrosurgery Modalities, Ultrasonic Devices, and Energy Safety 6.3 OR Fire Triangle, Laser Safety, and Emergency Management

7 Chapter 7: Wound Closure, Sutures, Needles, and Wound Healing

7.1 Suture Materials, Characteristics, and Sizing Standards 7.2 Surgical Needles, Tissue Staplers, and Mechanical Fasteners 7.3 Surgical Wound Classification, Complications, and Mechanisms of Healing

8 Chapter 8: Surgical Specialties I: General, OB/GYN, and GU Procedures

8.1 General and Gastrointestinal Surgical Procedures 8.2 Obstetric and Gynecologic Procedures 8.3 Genitourinary and Urological Procedures

9 Chapter 9: Surgical Specialties II: Orthopedic, Neuro, Cardiovascular, and ENT/Plastics

9.1 Orthopedic Trauma, Joint Arthroplasty, and Arthroscopy 9.2 Neurosurgical and Spine Procedures 9.3 Cardiothoracic and Peripheral Vascular Procedures 9.4 ENT, Ophthalmic, Maxillofacial, and Reconstructive Procedures

10 Chapter 10: Postoperative Care, Drains, Specimens, and Room Turnover

10.1 Surgical Dressings, Drains, and Urinary Catheter Management 10.2 Specimen Handling, Preservation, and Chain of Custody 10.3 Postoperative Room Breakdown, Terminal Cleaning, and Waste Management

11 Chapter 11: Surgical Pharmacology, Anesthesia, and Legal/Ethical Standards

11.1 Anesthesia Modalities, Phases, and Emergency Complications 11.2 Medication Handling, Delivery, and Calculations on the Sterile Field 11.3 Legal Doctrines, Scope of Practice, and Ethical Standards

11.2 Medication Handling, Delivery, and Calculations on the Sterile Field

Key Takeaways Explain This Topic AI

Safe medication handling on the sterile field follows the strict 'Six Rights' of Medication Administration (Right Patient, Right Drug, Right Dose, Right Route, Right Time, and Right Documentation) and requires dual-verbal and visual verification between the circulator and CST at each transfer step.

Every medication container, syringe, basin, and delivery device on the sterile field MUST be immediately labeled with the drug generic/brand name, concentration/strength, dosage form, date/time, and preparer initials—unlabeled medications are considered contaminated and must be immediately discarded.

Surgical technologists must possess absolute fluency in metric conversions (1 g = 1,000 mg, 1 mg = 1,000 mcg, 1 oz = 30 mL), percentage-to-milligram conversions (a 1% solution equals 10 mg/mL), ratio strengths (1:1,000 = 1 mg/mL; 1:100,000 = 10 mcg/mL), and dilution calculations using C1V1 = C2V2.

Major intraoperative pharmacological classes on the sterile field include local anesthetics (Lidocaine, Bupivacaine ± Epinephrine for vasoconstriction), topical hemostatics (Topical Thrombin—strictly prohibited from intravascular injection, Gelfoam, Surgicel, Avitene), anticoagulants (Heparin reversed 1:1 by Protamine Sulfate), radiopaque contrast media (Isovue, Omnipaque), and diagnostic dyes (Methylene Blue, Indigo Carmine).

Last updated: August 2026

11.2 Medication Handling, Delivery, and Calculations on the Sterile Field

Medication administration in the perioperative environment represents one of the most critical safety responsibilities shared between the circulator and the certified surgical technologist (CST). Unlike conventional inpatient floors where multiple automated checks exist before a nurse administers a drug, the sterile field requires real-time precision in transferring, measuring, diluting, labeling, and passing potent pharmaceuticals directly to the operating surgeon.

For the Tech in Surgery - Certified (NCCT TS-C) examination, medication delivery, dosage calculations, and sterile field pharmacology are heavily tested in the Perioperative Care Basic Science task area (drug uses, effects, and complications; the "Rights" of medication administration), the Communication and Reporting task (label medications and solutions appropriately), and End of Procedure Tasks (report totals of medications and solutions used). The CST must maintain zero tolerance for error, strictly upholding the Six Rights of Medication Administration, Joint Commission labeling mandates, and absolute mathematical accuracy.

1. The "Six Rights" and Aseptic Medication Transfer Protocols

Every medication accepted onto the sterile field must satisfy the fundamental Six Rights of Perioperative Medication Administration :

Right Patient: Verified during the pre-procedure Time-Out.

Right Drug: Generic and trade names checked against the surgeon's preference card and operative order.

Right Dose / Concentration: Strength, percentage, and total volume verified.

Right Route: Route specified (e.g., local infiltration, topical, intra-articular, irrigation; never IV by CST).

Right Time / Frequency: Administered at the correct surgical step.

Right Documentation: Exact drug name, concentration, volume received, volume administered, and volume remaining accurately reported to the circulator at case conclusion. +-----------------------------------------------------------------------------+

  • | MEDICATION TRANSFER & VERIFICATION WORKFLOW |
  • | |
  • | 1. CIRCULATOR HOLDS VIAL & READS ALOUD: |
  • | - Drug Name, Concentration, Expiration Date, Route/Purity |
  • | |
  • | 2. CST VISUALLY INSPECTS VIAL & REPEATS ALOUD: |
  • | - Confirms details match verbal statement and preference card |
  • | |
  • | 3. ASEPTIC TRANSFER VIA STERILE DEVICE: |
  • | - Sterile vial spike, transfer decanter, or filtered needle draw |
  • | - Never touch unsterile vial exterior; maintain 12-inch air boundary |
  • | |
  • | 4. IMMEDIATE STERILE FIELD LABELING: |
  • | - Medication basin/cup AND syringe labeled immediately |
  • | |
  • | 5. PASSING TO SURGEON WITH VERBAL CONFIRMATION: |
  • | - State aloud: "Lidocaine 1% with Epinephrine 1:100,000, 10 mL" |
  • +-----------------------------------------------------------------------------+
  • Dual-Verification Protocol (Step-by-Step)

First Check (Circulator): The circulator obtains the medication from pharmacy storage, verifying the vial label against the surgeon's preference card and patient chart.

Second Check (Joint Verification): The circulator presents the vial to the CST. Both the circulator and the CST read the vial label aloud together , confirming:

  • Full Generic and Trade Name
  • Strength and Concentration (e.g., 1 % 1\% 1% , 0.5 % 0.5\% 0.5% , 500 mg/mL 500\text{ mg/mL} 500 mg/mL )
  • Expiration Date and Lot Number
  • Special properties (e.g., with or without Epinephrine, preservative-free)
  • Integrity of the container and absence of particulate matter or discoloration

Third Check (Post-Transfer): The medication is transferred onto the sterile field using an aseptic transfer technique. The circulator holds the vial while the CST withdraws the medication using a sterile syringe with an 18-gauge blunt fill needle, or the circulator dispenses the solution via a sterile vial spike or decanter straw.

Fourth Check (Passing to Surgeon): When the CST hands the medication-filled syringe to the surgeon, the CST states the medication name and concentration aloud (e.g., "Here is 1% Lidocaine plain, 10 mL" ).

Aseptic Transfer Rules

Never Reach Over Basins: The circulator must never reach over the sterile field or hover directly above open sterile containers.

No Vial De-capping: Rubber stoppers must not be removed from vials to pour contents, as pouring over the unsterile glass lip risks fluid contamination.

Needle Safety & Recapping: Recapping contaminated needles using two hands is strictly prohibited by OSHA. If recapping is necessary on the back table, utilize the one-handed scoop technique or an engineered passive needle recapping block device.

2. Sterile Field Labeling Mandates and Safety Standards

Important

The Joint Commission National Patient Safety Goal (NPSG.03.04.01): All medications, medication containers (e.g., syringes, medicine cups, basins, squeeze bottles), and other solutions on and off the sterile field must be labeled immediately upon preparation or transfer if not immediately administered by the individual who prepared it.

Required Label Information

Every sterile field label must include:

  • Medication Name (Generic and/or Brand Name)
  • Concentration / Strength (e.g., 0.25 % 0.25\% 0.25% , 10 mg/mL 10\text{ mg/mL} 10 mg/mL )
  • Amount / Total Volume (if applicable)
  • Date and Time of preparation/opening
  • Expiration Date (if dated for less than 24 hours)

Initials of the CST who prepared the solution +-----------------------------------------------------------------------------+

  • | SAMPLE STERILE FIELD DRUG LABEL |
  • | |
  • | DRUG: Bupivacaine HCl (Marcaine) 0.5% with Epi 1:200,000 |
  • | DOSE: 5 mg/mL (Total Vol: 30 mL) |
  • | DATE: 2026-08-19 TIME: 08:30 AM |
  • | EXP: 24 Hours PREPARED BY: RC, CST |
  • +-----------------------------------------------------------------------------+
  • Management of Unlabeled Solutions

If any syringe, basin, or container is found unlabeled on the sterile back table or Mayo stand—even for a brief moment—it is considered contaminated . It must be immediately discarded along with the container and syringe, and fresh medication must be obtained and verified from the start.

3. Surgical Dosage Calculations and Metric Conversions

The surgical technologist must perform rapid, flawless mathematical conversions to verify drug dosages, calculate dilution strengths, and prevent fatal overdoses.

  • Metric System Foundations +-----------------------------------------------------------------------------+
  • | METRIC CONVERSION CONSTANTS |
  • | |
  • | 1 Kilogram (kg) = 1,000 Grams (g) = 2.2046 Pounds (lbs) |
  • | 1 Gram (g) = 1,000 Milligrams (mg) |
  • | 1 Milligram (mg) = 1,000 Micrograms (mcg / µg) |
  • | 1 Liter (L) = 1,000 Milliliters (mL) = 1,000 Cubic Centimeters |
  • | 1 Fluid Ounce (fl oz)= 30 Milliliters (mL) (approx. 29.57 mL) |
  • | 1 Teaspoon (tsp) = 5 Milliliters (mL) |
  • | 1 Tablespoon (tbsp) = 15 Milliliters (mL) |
  • +-----------------------------------------------------------------------------+
  • 1. Percentage Solution Calculations

In pharmaceutical formulations, a percentage solution expresses the weight of solute in grams per 100 mL 100\text{ mL} 100 mL of liquid solution: Percentage (%) = Grams of Solute 100 mL of Solution \text{Percentage (\%)} = \frac{\text{Grams of Solute}}{100\text{ mL of Solution}} Percentage (%) = 100 mL of Solution Grams of Solute ​

The "Multiply by 10" Rule: To convert a percentage concentration to milligrams per milliliter ( mg/mL \text{mg/mL} mg/mL ), multiply the percentage value by 10 . Concentration (mg/mL) = Percentage (%) × 10 \text{Concentration (mg/mL)} = \text{Percentage (\%)} \times 10 Concentration (mg/mL) = Percentage (%) × 10

Examples:

1 % 1\% 1% Lidocaine: 1 × 10 = 10 mg/mL 1 \times 10 = 10\text{ mg/mL} 1 × 10 = 10 mg/mL . A 30 mL 30\text{ mL} 30 mL vial contains 10 mg/mL × 30 mL = 300 mg 10\text{ mg/mL} \times 30\text{ mL} = 300\text{ mg} 10 mg/mL × 30 mL = 300 mg .

2 % 2\% 2% Lidocaine: 2 × 10 = 20 mg/mL 2 \times 10 = 20\text{ mg/mL} 2 × 10 = 20 mg/mL . A 20 mL 20\text{ mL} 20 mL vial contains 20 mg/mL × 20 mL = 400 mg 20\text{ mg/mL} \times 20\text{ mL} = 400\text{ mg} 20 mg/mL × 20 mL = 400 mg .

0.5 % 0.5\% 0.5% Bupivacaine (Marcaine): 0.5 × 10 = 5 mg/mL 0.5 \times 10 = 5\text{ mg/mL} 0.5 × 10 = 5 mg/mL . A 30 mL 30\text{ mL} 30 mL vial contains 5 mg/mL × 30 mL = 150 mg 5\text{ mg/mL} \times 30\text{ mL} = 150\text{ mg} 5 mg/mL × 30 mL = 150 mg .

0.25 % 0.25\% 0.25% Bupivacaine: 0.25 × 10 = 2.5 mg/mL 0.25 \times 10 = 2.5\text{ mg/mL} 0.25 × 10 = 2.5 mg/mL . A 50 mL 50\text{ mL} 50 mL bottle contains 2.5 mg/mL × 50 mL = 125 mg 2.5\text{ mg/mL} \times 50\text{ mL} = 125\text{ mg} 2.5 mg/mL × 50 mL = 125 mg .

2. Ratio Strength Solutions (Epinephrine Concentrations)

A ratio expresses parts of drug per parts of solution (e.g., 1 : 1 , 000 1:1,000 1 : 1 , 000 represents 1 g 1\text{ g} 1 g of drug in 1 , 000 mL 1,000\text{ mL} 1 , 000 mL of solution):

Ratio Strength Grams / mL Milligrams / mL Micrograms / mL Primary Perioperative Use

1 : 1,000 1 g / 1 , 000 mL 1\text{ g} / 1,000\text{ mL} 1 g /1 , 000 mL 1 mg/mL 1\text{ mg/mL} 1 mg/mL 1 , 000 mcg/mL 1,000\text{ mcg/mL} 1 , 000 mcg/mL Topical hemostasis (ENT vocal cord pledges); anaphylaxis IM. NEVER inject IV directly in volume.

1 : 10,000 1 g / 10 , 000 mL 1\text{ g} / 10,000\text{ mL} 1 g /10 , 000 mL 0.1 mg/mL 0.1\text{ mg/mL} 0.1 mg/mL 100 mcg/mL 100\text{ mcg/mL} 100 mcg/mL IV cardiac arrest resuscitation (ACLS bolus).

1 : 100,000 1 g / 100 , 000 mL 1\text{ g} / 100,000\text{ mL} 1 g /100 , 000 mL 0.01 mg/mL 0.01\text{ mg/mL} 0.01 mg/mL 10 mcg/mL 10\text{ mcg/mL} 10 mcg/mL High-vasoconstriction local infiltration (plastics, oral surgery).

1 : 200,000 1 g / 200 , 000 mL 1\text{ g} / 200,000\text{ mL} 1 g /200 , 000 mL 0.005 mg/mL 0.005\text{ mg/mL} 0.005 mg/mL 5 mcg/mL 5\text{ mcg/mL} 5 mcg/mL Standard local anesthetic commercial additive (Lidocaine/Marcaine).

3. Dilution Equation ( C 1 V 1 = C 2 V 2 C_1V_1 = C_2V_2 C 1 ​ V 1 ​ = C 2 ​ V 2 ​ )

When preparing a diluted solution from a concentrated stock solution: C 1 × V 1 = C 2 × V 2 C_1 \times V_1 = C_2 \times V_2 C 1 ​ × V 1 ​ = C 2 ​ × V 2 ​

Where:

  • C 1 = C_1 = C 1 ​ = Initial stock concentration
  • V 1 = V_1 = V 1 ​ = Initial volume of stock solution needed
  • C 2 = C_2 = C 2 ​ = Final desired concentration
  • V 2 = V_2 = V 2 ​ = Final total volume of diluted solution

Clinical Calculation Example: The surgeon requests 100 mL 100\text{ mL} 100 mL of 0.5 % 0.5\% 0.5% Lidocaine. You only have 2 % 2\% 2% Lidocaine stock on hand. How much 2 % 2\% 2% Lidocaine and how much sterile saline must you mix? C 1 × V 1 = C 2 × V 2 ⟹ 2 % × V 1 = 0.5 % × 100 mL C_1 \times V_1 = C_2 \times V_2 \implies 2\% \times V_1 = 0.5\% \times 100\text{ mL} C 1 ​ × V 1 ​ = C 2 ​ × V 2 ​ ⟹ 2% × V 1 ​ = 0.5% × 100 mL V 1 = 0.5 × 100 2 = 50 2 = 25 mL V_1 = \frac{0.5 \times 100}{2} = \frac{50}{2} = 25\text{ mL} V 1 ​ = 2 0.5 × 100 ​ = 2 50 ​ = 25 mL

Solution: Draw 25 mL 25\text{ mL} 25 mL of 2 % 2\% 2% Lidocaine and mix with 75 mL 75\text{ mL} 75 mL of sterile normal saline ( 100 mL − 25 mL = 75 mL 100\text{ mL} - 25\text{ mL} = 75\text{ mL} 100 mL − 25 mL = 75 mL ) to yield 100 mL 100\text{ mL} 100 mL of 0.5 % 0.5\% 0.5% Lidocaine.

4. Maximum Safe Dosage Calculations

Local anesthetics have strict weight-based toxic thresholds:

Local Anesthetic Plain Maximum Dose Maximum with Epinephrine Onset of Action Duration of Action

Lidocaine (Xylocaine) 4.5 mg/kg 4.5\text{ mg/kg} 4.5 mg/kg (Max: 300 mg 300\text{ mg} 300 mg ) 7.0 mg/kg 7.0\text{ mg/kg} 7.0 mg/kg (Max: 500 mg 500\text{ mg} 500 mg ) Rapid (2–5 min) Short/Moderate (1–2 hrs; 2–4 hrs with Epi)

Bupivacaine (Marcaine) 2.5 mg/kg 2.5\text{ mg/kg} 2.5 mg/kg (Max: 175 mg 175\text{ mg} 175 mg ) 3.0 mg/kg 3.0\text{ mg/kg} 3.0 mg/kg (Max: 225 mg 225\text{ mg} 225 mg ) Slow (5–15 min) Long (4–8 hrs; 6–12 hrs with Epi)

Ropivacaine (Naropin) 3.0 mg/kg 3.0\text{ mg/kg} 3.0 mg/kg (Max: 200 mg 200\text{ mg} 200 mg ) 3.5 mg/kg 3.5\text{ mg/kg} 3.5 mg/kg (Max: 250 mg 250\text{ mg} 250 mg ) Moderate (5–10 min) Long (4–8 hrs; less cardiotoxic than Marcaine)

Clinical Calculation Example: What is the maximum safe volume of 1 % 1\% 1% Lidocaine with Epinephrine ( 1 : 100 , 000 1:100,000 1 : 100 , 000 ) that can be administered to a 70 kg 70\text{ kg} 70 kg adult patient?

Calculate max dose in mg: 70 kg × 7 mg/kg = 490 mg 70\text{ kg} \times 7\text{ mg/kg} = 490\text{ mg} 70 kg × 7 mg/kg = 490 mg (below the absolute 500 mg 500\text{ mg} 500 mg cap).

Calculate mg/mL of 1 % 1\% 1% solution: 1 × 10 = 10 mg/mL 1 \times 10 = 10\text{ mg/mL} 1 × 10 = 10 mg/mL .

Calculate volume in mL: 490 mg 10 mg/mL = 49 mL \frac{490\text{ mg}}{10\text{ mg/mL}} = 49\text{ mL} 10 mg/mL 490 mg ​ = 49 mL .

  • 4. Comprehensive Sterile Field Pharmacology Matrix
  • 1. Local Anesthetics (Amides vs. Esters)

Amides (contain two letter "i"s in generic name): Lidocaine, Bupivacaine, Ropivacaine, Mepivacaine. Metabolized primarily by hepatic microsomal enzymes in the liver ; low incidence of true allergic hypersensitivity.

Esters (contain one letter "i" in generic name): Cocaine, Procaine (Novocain), Tetracaine (Pontocaine). Metabolized in plasma by pseudocholinesterase ; higher allergic potential due to the metabolite para-aminobenzoic acid ( PABA ).

Cocaine Hydrochloride (4% / 10% topical): The only local anesthetic that produces intrinsic vasoconstriction by blocking norepinephrine reuptake. Strictly used topically on mucous membranes in ENT surgery (rhinoplasty, septoplasty); strictly prohibited from systemic or local injection (fatal hypertension/arrhythmias).

Role of Epinephrine in Local Infiltration:

Vasoconstricts local microvasculature -> minimizes operative bleeding.

Slows systemic absorption -> reduces peak plasma drug levels and toxicity.

Prolongs duration of the local anesthetic block by up to 50–100%.

Absolute Contraindications: Areas supplied by end-arteries with no collateral flow (digits of fingers/toes, penis, tip of nose, earlobes) due to severe risk of vasospasm, tissue ischemia, and gangrene.

  • 2. Topical Hemostatic Agents +-----------------------------------------------------------------------------+
  • | TOPICAL HEMOSTAT TAXONOMY |
  • | |
  • | MECHANICAL MATRICES -> Gelfoam, Surgicel, Oxycel, Avitene |
  • | ACTIVE ENZYMATIC -> Topical Thrombin (Bovine, Recombinant) |
  • | FLOWABLE AGENTS -> FloSeal, Surgiflo (Gelatin granules + Thrombin) |
  • | FIBRIN SEALANTS -> Tisseel, Evicel (Fibrinogen + Thrombin) |
  • | CHEMICAL CAUTERANTS -> Silver Nitrate, Monsel's Solution (Ferric Subsulf)|
  • +-----------------------------------------------------------------------------+

Absorbable Gelatin (Gelfoam / Surgifoam): Porous animal-skin collagen matrix that absorbs 40–50 times its weight in blood, promoting platelet entrapment. Absorbed in 4–6 weeks. Frequently soaked in Topical Thrombin.

Oxidized Regenerated Cellulose (Surgicel / Nu-Knit / Fibrillar): Plant cellulose treated with nitrogen dioxide; turns into an acidic dark gelatinous mass upon contact with blood, activating extrinsic clotting and exerting intrinsic antibacterial properties. Absorbed in 7–14 days. Must be removed from bony or neural foramina to prevent compression edema.

Microfibrillar Collagen Hemostat (MCH / Avitene): Dry, fluffy fibrous collagen derived from bovine corium. Applied strictly dry with dry forceps directly onto bleeding oozing surfaces, triggering platelet aggregation and instantaneous clot formation. Avoid applying to skin edges as it inhibits wound healing.

Topical Thrombin (Evithrom / Recothrom): Lyophilized active clotting factor IIa (converts fibrinogen directly to fibrin). Reconstituted with sterile saline.

Caution

Topical Thrombin Warning: Thrombin is formulated STRICTLY FOR TOPICAL APPLICATION ONLY . Never inject Thrombin into vascular lumens, arteries, or veins. Inadvertent intravascular injection causes instantaneous, catastrophic, widespread intravascular coagulation (DIC) and immediate death.

3. Anticoagulants and Emergency Reversal Agents

Heparin Sodium: Parenteral anticoagulant that binds antithrombin III, inactivating Thrombin (Factor IIa) and Factor Xa, preventing clot formation.

Vascular Surgery Dosing: Systemic bolus (100–300 units/kg) before arterial clamping; topical vascular flush (5,000 units in 1,000 mL normal saline = 5 units/mL).

Protamine Sulfate: Specific antagonist and reversal agent for Heparin. A positively charged alkaline protein derived from salmon sperm that forms a stable, inactive neutral salt complex with negatively charged acidic heparin.

Dosing: 1 mg 1\text{ mg} 1 mg Protamine neutralizes approximately 100 units 100\text{ units} 100 units of circulating Heparin.

Administration Caution: Must be infused slowly IV over 10 minutes; rapid injection causes profound systemic hypotension, acute pulmonary vasoconstriction, and fatal anaphylactoid shock.

Tranexamic Acid (TXA): Synthetic lysine-analogue antifibrinolytic agent that competitively inhibits plasminogen activation to plasmin, preventing premature clot breakdown. Widely used in orthopedic arthroplasty, trauma, and cardiac surgery to reduce blood loss and transfusion requirements.

4. Radiopaque Contrast Media and Diagnostic Dyes

Agent Category Specific Examples Clinical Applications & Target Organs Special Handling & Cautions

Radiopaque Contrast Media Iohexol (Omnipaque) , Iopamidol (Isovue) , Diatrizoate (Hypaque) Intraoperative fluoroscopic imaging: Cholangiograms (biliary tree), Angiograms (arterial lumen), Retrograde Ureteral Pyelograms (renal pelvis). Radiopaque (white on X-ray); contains organic iodine (screen for shellfish/iodine allergy); sensitive to light; keep separated from clear local anesthetics.

Diagnostic Dyes Methylene Blue Visual identification: Fallopian tube patency (Chromopertubation in OB/GYN), ureteral or bladder laceration detection, skin marking. Highly staining; pass carefully; do not inject IV in large doses with SSRI medications (causes serotonin syndrome).

Indigo Carmine IV dye excreted intact by kidneys into urine within 5–15 minutes. Visualized during cystoscopy exiting ureteral orifices ( "ureteral jets" ). Used to verify ureteral integrity during hysterectomy or pelvic dissection; blue color indicates brisk renal clearance.

Isosulfan Blue (Lymphazurin) / Indocyanine Green (ICG) Lymphatic mapping: Delineates lymphatic drainage to identify the sentinel lymph node in breast cancer and melanoma surgery. Injected subdermally around tumor; Lymphazurin causes transient blue skin discoloration and false pulse oximetry drop.

Gentian Violet Sterile surgical skin marking ink. Prepackaged sterile skin markers; never use unsterile standard ink pens on surgical skin.

5. Surgical Irrigation Solutions and Distension Media

0.9% Sodium Chloride (Normal Saline): Isotonic ( 308 mOsm/L 308\text{ mOsm/L} 308 mOsm/L ), standard for general wound irrigation, peritoneal cavity washing, and moistening sponges/cottonoids. Conductive: contraindicated with monopolar electrosurgery in endoscopic fluid cavities.

Sterile Water for Irrigation: Hypotonic ( 0 mOsm/L 0\text{ mOsm/L} 0 mOsm/L ); causes rapid osmotic cell lysis. Used in cancer resection beds (to lyse shed neoplastic tumor cells) and during Transurethral Resection of Bladder Tumor (TURBT). Hazard: Intravascular absorption in large volumes causes severe hemolysis and fatal hyponatremia; never used for cell saver autotransfusion washing.

Non-Electrolytic Distension Solutions (Glycine 1.5%, Sorbitol 3%, Mannitol): Non-conductive fluids utilized to distend the bladder during monopolar Transurethral Resection of the Prostate (TURP) or the uterus during hysteroscopy without dissipating electrical current.

Complication: TURP Syndrome (Fluid Overload / Dilutional Hyponatremia): Absorption of large volumes of non-electrolytic fluid through opened venous sinuses causing hypervolemic heart failure, pulmonary edema, severe hyponatremia ( N a + < 120 mEq/L Na^+ < 120\text{ mEq/L} N a + < 120 mEq/L ), cerebral edema, seizures, and visual disturbances.